INTERNATIONAL PATENT: THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. FILES APPLICATION FOR "NOVEL RUFOMYCIN ANALOGS AS CLPC1 PROTEASE MODULATORS HAVING ACTIVITY AGAINST MYCOBACTERIUM TUBERCULOSIS"

GENEVA, Jan. 29 -- THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (80 Pine Street, 20th FloorNew York, NY 10005) filed a patent application (PCT/US2024/038472) for "NOVEL RUFOMYCIN ANALOGS AS CLPC1 PROTEASE MODULATORS HAVING ACTIVITY AGAINST MYCOBACTERIUM TUBERCULOSIS" on Jul 18, 2024. With publication no. WO/2025/019632, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FOTOUHI, Nader (3 Conkling St.Basking Ridge, NJ 07920), LI, Guiying (275 Hoym St, 1cFort Lee, NJ 07024), KANEKO, Takushi (398 Northwood DriveGuilford, C...